1.
J Clin Exp Hepatol
; 12(3): 1007-1011, 2022.
Article
in English
| MEDLINE | ID: covidwho-1561499
ABSTRACT
Liver transplant recipients are at an increased risk of opportunistic infections due to the use of immunosuppression. Coronavirus disease of 2019 (COVID-19) increases the risk of these infections further due to associated immune dysfunction and the use of high-dose steroids. We present a case of a liver transplant recipient who developed disseminated tuberculosis and invasive pulmonary aspergillosis complicated by acquired hemophagocytic lymphohistiocytosis after recovering from severe COVID-19.
2.
Int J Lab Hematol
; 43(6): e300-e302, 2021 12.
Article
in English
| MEDLINE | ID: covidwho-1258938